Management of Cancer-Associated Venous Thromboembolism in the Emergency Department

Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-a...

Full description

Saved in:
Bibliographic Details
Published in:Annals of emergency medicine 2017-06, Vol.69 (6), p.768-776
Main Authors: Nene, Rahul V., PhD, Coyne, Christopher J., MD, MPH
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Contraindications
Emergency
Emergency Service, Hospital
Guidelines as Topic
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Neoplasms - complications
Practice Guidelines as Topic
Recurrence
Risk Factors
Secondary Prevention - methods
Venous Thromboembolism - drug therapy
Venous Thromboembolism - prevention & control
Vitamin K - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with cancer are at increased risk of venous thromboembolism, and emergency physicians can play a significant role in addressing one of the leading causes of morbidity and mortality in this patient population. However, there are no comprehensive guidelines addressing the approach to cancer-associated venous thromboembolism in the emergency department. Here, we review the guidelines put forth by various national and international cancer societies and highlight how emergency physicians can help institute appropriate treatment and prevent the recurrence of venous thromboembolism in cancer patients. We also address areas of controversy and highlight topics that require further research.
ISSN:0196-0644
1097-6760
DOI:10.1016/j.annemergmed.2016.12.003